Stocks in News Today

Our analysts at 5paisa scan through the financial markets and select the few trending stocks in the news and in the limelight for the day. Here is the list of a few trending stocks with their latest News and Updates.

Join the club of lakhs of tech-savvy investors!

Open Account Now

Trending Stocks Today: 12-Dec-2024

1. Grasim Industries

The flagship company of the Aditya Birla Group, Grasim Industries, has given the green light to raise ₹2,000 crore through Non-Convertible Debentures (NCDs) on a private placement basis. The Finance Committee approved this during its Wednesday meeting, mentioning the NCDs would be issued in one or more installments. This decision was officially disclosed in a regulatory filing with the stock exchanges.

2. Reliance Power

Under the leadership of Anil Ambani, Reliance Power announced that Reliance NU Suntech Private Ltd, a subsidiary, has secured a 930 MW solar project that includes a Battery Energy Storage System (BESS). This project was awarded by the Solar Energy Corporation of India (SECI) on December 9, 2024, through an e-reverse auction. With SECI's Letter of Award (LoA) still pending, the system will have a minimum storage capacity of 465 MW/1,860 MWh.

3. Cipla

Cipla announced receiving approval from the Central Drugs Standard Control Organisation (CDSCO) to distribute and market Afrezza (insulin human) Inhalation Powder in India. Manufactured by MannKind Corporation in the USA, this product aims to enhance glycemic control for adults with diabetes mellitus. By introducing this innovative solution, Cipla seeks to transform diabetes management in India and provide patients with a more convenient health solution.

4. Vedanta

On Monday, December 16, Vedanta's board will meet under the direction of Anil Agarwal to discuss the company's fourth interim dividend. Due to unanticipated circumstances, this meeting that was originally scheduled for October was postponed. After two previous payouts of ₹11 and ₹4 per share, Vedanta paid its third interim dividend earlier in September, this time at ₹20 per share.

5. Gland Pharma

Gland Pharma has secured approval from the United States Food and Drug Administration (FDA) for its phytonadione injectable emulsion USP, 10 mg/mL, supplied in single-dose ampoules. This medication, equivalent to Hospira Inc.’s vitamin K1 injectable emulsion, addresses coagulation issues caused by vitamin K deficiencies.

Also, check Stocks to Buy Today: 5 Best Shares to Trade Online